A detailed history of Credit Suisse Ag transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 847,885 shares of TMDX stock, worth $52.9 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
847,885
Previous 859,478 1.35%
Holding current value
$52.9 Million
Previous $67.8 Million 7.59%
% of portfolio
0.06%
Previous 0.07%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$70.86 - $89.93 $821,479 - $1.04 Million
-11,593 Reduced 1.35%
847,885 $62.7 Million
Q4 2023

Feb 08, 2024

SELL
$36.74 - $81.08 $10 Million - $22.1 Million
-272,425 Reduced 24.07%
859,478 $67.8 Million
Q3 2023

Nov 13, 2023

BUY
$53.47 - $96.07 $18.4 Million - $33.1 Million
344,635 Added 43.78%
1,131,903 $62 Million
Q2 2023

Aug 11, 2023

SELL
$66.23 - $88.73 $2.3 Million - $3.08 Million
-34,741 Reduced 4.23%
787,268 $66.1 Million
Q1 2023

May 10, 2023

SELL
$53.63 - $82.33 $11.5 Million - $17.7 Million
-215,288 Reduced 20.75%
822,009 $62.3 Million
Q4 2022

Feb 13, 2023

SELL
$39.08 - $64.29 $5 Million - $8.23 Million
-128,028 Reduced 10.99%
1,037,297 $64 Million
Q3 2022

Nov 10, 2022

SELL
$31.56 - $55.75 $10.3 Million - $18.1 Million
-325,325 Reduced 21.82%
1,165,325 $48.6 Million
Q2 2022

Aug 12, 2022

SELL
$20.56 - $32.15 $552,591 - $864,095
-26,877 Reduced 1.77%
1,490,650 $46.9 Million
Q1 2022

May 16, 2022

BUY
$12.58 - $26.94 $14,580 - $31,223
1,159 Added 0.08%
1,517,527 $40.9 Million
Q4 2021

Feb 14, 2022

BUY
$19.16 - $32.68 $1,437 - $2,451
75 Added 0.0%
1,516,368 $29.1 Million
Q3 2021

Nov 12, 2021

BUY
$25.92 - $34.51 $60,445 - $80,477
2,332 Added 0.15%
1,516,293 $50.2 Million
Q2 2021

Aug 16, 2021

BUY
$21.63 - $40.07 $242,126 - $448,543
11,194 Added 0.74%
1,513,961 $50.2 Million
Q1 2021

May 14, 2021

SELL
$17.75 - $47.82 $73,236 - $197,305
-4,126 Reduced 0.27%
1,502,767 $62.4 Million
Q4 2020

Feb 12, 2021

BUY
$11.91 - $19.9 $98,686 - $164,891
8,286 Added 0.55%
1,506,893 $30 Million
Q3 2020

Nov 13, 2020

BUY
$13.78 - $18.84 $2.7 Million - $3.69 Million
195,849 Added 15.03%
1,498,607 $20.7 Million
Q2 2020

Aug 12, 2020

BUY
$11.66 - $18.26 $1.2 Million - $1.87 Million
102,537 Added 8.54%
1,302,758 $23.3 Million
Q1 2020

May 13, 2020

BUY
$10.5 - $20.2 $717,948 - $1.38 Million
68,376 Added 6.04%
1,200,221 $14.5 Million
Q4 2019

Feb 12, 2020

BUY
$16.61 - $21.64 $6.07 Million - $7.9 Million
365,271 Added 47.65%
1,131,845 $21.5 Million
Q3 2019

Nov 12, 2019

BUY
$20.27 - $28.93 $2.34 Million - $3.34 Million
115,534 Added 17.75%
766,574 $18.2 Million
Q2 2019

Aug 14, 2019

BUY
$22.36 - $30.41 $14.6 Million - $19.8 Million
651,040 New
651,040 $18.9 Million

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $1.98B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.